Stocks · Industrials · Services-Testing Laboratories

NEOGENOMICS INC

NEO Clue Score37
United States Fiscal year ends December CIK 0001077183 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Lynn A. Tetrault
22 May 2023
Director
Exercised, kept
1,507
$11.60
$17.48K
Lynn A. Tetrault
18 May 2022
Director
Exercised, kept
3,334
$7.27
$24.24K
William Bonello
28 Apr 2022
Chief Financial Officer
Exercised, kept
5,727
$7.52
$43.07K
William Bonello
8 Mar 2022
Chief Financial Officer
Exercised, kept
5,000
$7.52
$37.60K
Kathryn B McKenzie
11 Jan 2022
Chief Sustainability/Risk Ofcr
Exercised, kept
2,100
$9.07
$19.05K
Kevin C Johnson
22 Dec 2021
Director
Exercised, kept
3,334
$7.27
$24.24K
Kathryn B McKenzie
22 Dec 2021
Chief Financial Officer
Exercised, kept
5,000
$9.07
$45.35K
William Bonello
30 Nov 2021
President, Informatics
Exercised, kept
25,000
$7.52
$188.00K
Lynn A. Tetrault
11 Jun 2021
Director
Exercised, kept
1,389
$9.11
$12.65K
Lawrence Martin Weiss
22 Apr 2021
Chief Medical Officer
Exercised, kept
9,378
$28.33
$265.68K
Lawrence Martin Weiss
22 Apr 2021
Chief Medical Officer
Exercised, kept
9,005
$19.60
$176.50K
Lawrence Martin Weiss
22 Apr 2021
Chief Medical Officer
Exercised, kept
6,667
$9.22
$61.47K
Steven C Jones
7 Jan 2021
Director
Exercised, kept
4,269
$22.52
$96.14K
Steven C Jones
7 Jan 2021
Director
Exercised, kept
3,017
$11.60
$35.00K
Steven C Jones
7 Jan 2021
Director
Exercised, kept
10,000
$7.27
$72.70K
Steven C Jones
7 Jan 2021
Director
Exercised, kept indirect
100,000
$7.15
$715.00K
Alison L. Hannah
6 Aug 2020
Director
Exercised, kept
10,000
$7.27
$72.70K
Bruce K Crowther
1 May 2020
Director
Exercised, kept
10,000
$4.78
$47.80K
Steven C Jones
13 Mar 2020
Director
Exercised, kept indirect
125,000
$4.78
$597.50K
Steven C Jones
30 Dec 2019
Director
Exercised, kept indirect
100,000
$4.78
$478.00K
Oort Douglas M Van
8 Nov 2019
Chairman and CEO
Exercised, kept
472,527
$7.15
$3.38M
Kevin C Johnson
31 Oct 2019
Director
Exercised, kept
3,017
$11.60
$35.00K
Kevin C Johnson
31 Oct 2019
Director
Exercised, kept
6,666
$7.27
$48.46K
Kevin C Johnson
31 Oct 2019
Director
Exercised, kept
8,333
$9.11
$75.91K
Kevin C Johnson
31 Oct 2019
Director
Exercised, kept
6,667
$4.78
$31.87K
Alison L. Hannah
9 Sep 2019
Director
Exercised, kept
8,333
$9.11
$75.91K
Alison L. Hannah
9 Sep 2019
Director
Exercised, kept
3,333
$6.66
$22.20K
George Cardoza
2 May 2019
President, Pharma Services
Exercised, kept
200,000
$4.78
$956.00K
Jennifer Balliet
2 May 2019
VP and Chief Culture Officer
Exercised, kept
13,333
$7.52
$100.26K
Jennifer Balliet
2 May 2019
VP and Chief Culture Officer
Exercised, kept
16,667
$7.15
$119.17K
Robert J. Shovlin
28 Feb 2019
President, Clinical Services
Exercised, kept
13,986
$7.15
$100.00K
George Cardoza
27 Feb 2019
President, Pharma Services
Exercised, kept
30,000
$3.45
$103.50K
Lynn A. Tetrault
15 Nov 2018
Director
Exercised, kept
3,333
$7.27
$24.23K
Lynn A. Tetrault
15 Nov 2018
Director
Exercised, kept
5,555
$9.11
$50.61K
Lynn A. Tetrault
15 Nov 2018
Director
Exercised, kept
10,000
$6.66
$66.60K
Steven G. Brodie
22 Oct 2018
VP - Pharma Operations
Exercised, kept
13,334
$3.45
$46.00K
Jennifer Balliet
28 Mar 2018
VP and Chief Culture Officer
Exercised, kept
7,000
$4.78
$33.46K
Jennifer Balliet
24 Aug 2017
VP and Chief Culture Officer
Exercised, kept
7,500
$3.76
$28.20K
Jennifer Balliet
24 Aug 2017
VP and Chief Culture Officer
Exercised, kept
15,000
$3.45
$51.75K
Alison L. Hannah
9 Aug 2017
Director
Exercised, kept
6,667
$6.66
$44.40K
Steven G. Brodie
5 Jul 2017
Vice President of Operations
Exercised, kept
6,666
$3.45
$23.00K
Steven G. Brodie
27 Mar 2017
President, Pharma Services
Exercised, kept
10,000
$3.76
$37.60K
Jennifer Balliet
27 Feb 2017
VP and Chief Culture Officer
Exercised, kept
6,250
$1.69
$10.56K
Oort Douglas M Van
2 Feb 2017
Chairman and CEO
Exercised, kept
200,000
$1.71
$342.00K
Kevin C Johnson
3 Jan 2017
Director
Exercised, kept
3,333
$4.78
$15.93K
Steven G. Brodie
6 Dec 2016
President, Pharma Services
Exercised, kept
10,000
$1.69
$16.90K

What was left out

Form 4 filings counted 395
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 43
Sales at will 87
Transactions with no price 0
Shares from compensation/vesting 9,474,898
Sales filed before the plan box existed 86
History held since 9 May 2011